Pediatric blood disorders include a wide range of conditions that affect red blood cells, white blood cells and platelets, as well as blood proteins related to bleeding and clotting disorders.
Some of these conditions are inherited and passed down from parents who carry the abnormal (mutated) gene. Others are acquired.
Children with blood disorders are treated through the Blood Disorders Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children's Hospital.
Our Pediatric Blood Disorders team is internationally known for its wide range of clinical, research, teaching and laboratory services. Annually, we treat approximately 1,100 new patients and families with all forms of non-malignant blood disorders. These include anemias (e.g. sickle cell, thalassemia, iron deficiency, sideroblastic); bone marrow failure syndromes (e.g. Fanconi anemia, aplastic anemia, Diamond Blackfan anemia); bleeding problems (e.g. hemophilia, von Willebrand disease); blood clots (thrombosis); platelet disorders (e.g. immune thrombocytopenic purpura (ITP); and white blood cell disorders.
Our multidisciplinary approach to care ensures personalized management plans that
meet the medical, physical, emotional and informational needs of each patient and
family. Our team integrates expertise from:
- highly skilled and experienced pediatric hematologists, pediatric hematology
nurse practitioners and nurses
- experts from every pediatric medical subspecialty, including immunologists and
hematopathologists (pathologists specializing in childhood blood disorders),
- social workers, child life specialists, psychologists, and clinical dietitians who
provide supportive care before, during and after treatment
Please visit the main Dana-Farber/Boston Children's website to learn more about our Blood Disorders Center, including: